These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 25561791)

  • 21. Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells.
    Liu S; Li N; Yu X; Xiao X; Cheng K; Hu J; Wang J; Zhang D; Cheng S; Liu S
    Gastroenterology; 2013 May; 144(5):1031-1041.e10. PubMed ID: 23376424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
    Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer stem cells in hepatocellular carcinoma--an immunohistochemical study with histopathological association.
    Matthai SM; Ramakrishna B
    Indian J Med Res; 2015 Oct; 142(4):391-8. PubMed ID: 26609030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC.
    Helaly GF; Abou Shamaa LA
    Egypt J Immunol; 2006; 13(1):27-38. PubMed ID: 17974148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma.
    El-Mazny A; Sayed M; Sharaf S
    Arab J Gastroenterol; 2014 Jun; 15(2):68-71. PubMed ID: 25097049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence of CD90+CXCR4+ cells as circulating tumor stem cells in hepatocellular carcinoma.
    Zhu L; Zhang W; Wang J; Liu R
    Tumour Biol; 2015 Jul; 36(7):5353-60. PubMed ID: 25672610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
    Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
    Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum miRNA Panel in Egyptian Patients with Chronic Hepatitis C Related Hepatocellular Carcinoma.
    Khairy A; Hamza I; Shaker O; Yosry A
    Asian Pac J Cancer Prev; 2016; 17(5):2699-703. PubMed ID: 27268654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of cyclins and cyclin dependent kinases in development and progression of hepatitis C virus-genotype 4-associated hepatitis and hepatocellular carcinoma.
    Bahnassy AA; Zekri AR; Loutfy SA; Mohamed WS; Moneim AA; Salem SE; Sheta MM; Omar A; Al-Zawahry H
    Exp Mol Pathol; 2011 Oct; 91(2):643-52. PubMed ID: 21801719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated serum microRNA-122/222 levels are potential diagnostic biomarkers in Egyptian patients with chronic hepatitis C but not hepatic cancer.
    Motawi TM; Sadik NA; Shaker OG; Ghaleb MH
    Tumour Biol; 2016 Jul; 37(7):9865-74. PubMed ID: 26812693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AFP mRNA level in enriched circulating tumor cells from hepatocellular carcinoma patient blood samples is a pivotal predictive marker for metastasis.
    Jin J; Niu X; Zou L; Li L; Li S; Han J; Zhang P; Song J; Xiao F
    Cancer Lett; 2016 Aug; 378(1):33-7. PubMed ID: 27160647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
    Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A
    J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection.
    Zekri AN; El-Sisi ER; Youssef ASE; Kamel MM; Nassar A; Ahmed OS; El Kassas M; Barakat AB; Abd El-Motaleb AI; Bahnassy AA
    PLoS One; 2018; 13(3):e0193709. PubMed ID: 29534065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Capturing circulating tumor cells of hepatocellular carcinoma.
    Wu LJ; Pan YD; Pei XY; Chen H; Nguyen S; Kashyap A; Liu J; Wu J
    Cancer Lett; 2012 Dec; 326(1):17-22. PubMed ID: 22842097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular Carcinoma.
    Guo W; Sun YF; Shen MN; Ma XL; Wu J; Zhang CY; Zhou Y; Xu Y; Hu B; Zhang M; Wang G; Chen WQ; Guo L; Lu RQ; Zhou CH; Zhang X; Shi YH; Qiu SJ; Pan BS; Cao Y; Zhou J; Yang XR; Fan J
    Clin Cancer Res; 2018 May; 24(9):2203-2213. PubMed ID: 29374055
    [No Abstract]   [Full Text] [Related]  

  • 37. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
    Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
    Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma.
    Kalinich M; Bhan I; Kwan TT; Miyamoto DT; Javaid S; LiCausi JA; Milner JD; Hong X; Goyal L; Sil S; Choz M; Ho U; Kapur R; Muzikansky A; Zhang H; Weitz DA; Sequist LV; Ryan DP; Chung RT; Zhu AX; Isselbacher KJ; Ting DT; Toner M; Maheswaran S; Haber DA
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1123-1128. PubMed ID: 28096363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating visfatin level is associated with hepatocellular carcinoma in chronic hepatitis B or C virus infection.
    Tsai IT; Wang CP; Yu TH; Lu YC; Lin CW; Lu LF; Wu CC; Chung FM; Lee YJ; Hung WC; Hsu CC
    Cytokine; 2017 Feb; 90():54-59. PubMed ID: 27770715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IGFBP1 in epithelial circulating tumor cells as a potential response marker to selective internal radiation therapy in hepatocellular carcinoma.
    Nel I; Baba HA; Weber F; Sitek B; Eisenacher M; Meyer HE; Schlaak JF; Hoffmann AC
    Biomark Med; 2014; 8(5):687-98. PubMed ID: 25123037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.